OpenURL Connection Search

Select item for more details and to access through your institution.

Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects.
Published in:
QJM: An International Journal of Medicine, 2011, v. 104, n. 11, p. 957
By:
- Dubrey, S.W.;
- Reece, D.E.;
- Sanchorawala, V.;
- Hegenbart, U.;
- Merlini, G.;
- Palladini, G.;
- Fermand, J.-P.;
- Vescio, R.A.;
- Bladé, J.;
- Heffner, L.T.;
- Hassoun, H.;
- Liu, X.;
- Enny, C.;
- Ramaswami, P.;
- Elsayed, Y.;
- Van De Velde, H.;
- Mortimer, S.;
- Cakana, A.;
- Comenzo, R.L.
Publication type:
Article
Experiments in Machine Learning Using Artificial Neural Networks for Control and Image Compression.
Published in:
Computer Applications in Engineering Education, 1995, v. 3, n. 3, p. 195, doi. 10.1002/cae.6180030307
By:
- Watta, Paul B.;
- Hassoun, Mohamad H.
Publication type:
Article
Does a patient with hereditary spherocytosis qualify for preoperative autologous blood donation?
Published in:
Transfusion, 1997, v. 37, n. 11/12, p. 1179, doi. 10.1046/j.1537-2995.1997.37111298088049.x
By:
- Weinstein, R.;
- Martinez, R.;
- Hassoun, H.;
- Palek, J.
Publication type:
Article
Does a patient with hereditary spherocytosis qualify for preoperative autologous blood donation?
Published in:
Transfusion, 1997, v. 37, n. 11, p. 1179
By:
- Weinstein, R.;
- Martinez, R.;
- Hassoun, H.;
- Palek, J.
Publication type:
Article
Catalog of total excitation-emission and total synchronous fluorescence maps with synchronous fluorescence spectra of homologated fluorescent pesticides in large use in Morocco: development of a spectrometric low cost and direct analysis as an alert method in case of massive contamination of soils and waters by fluorescent pesticides
Published in:
Environmental Science & Pollution Research, 2015, v. 22, n. 9, p. 6766, doi. 10.1007/s11356-014-3807-6
By:
- Foudeil, S.;
- Hassoun, H.;
- Lamhasni, T.;
- Ait Lyazidi, S.;
- Benyaich, F.;
- Haddad, M.;
- Choukrad, M.;
- Boughdad, A.;
- Bounakhla, M.;
- Bounouira, H.;
- Duarte, R.;
- Cachada, A.;
- Duarte, A.
Publication type:
Article
Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 8, p. 1033, doi. 10.1038/bmt.2012.281
By:
- Pozotrigo, M;
- Adel, N;
- Landau, H;
- Lesokhin, A;
- Lendvai, N;
- Chung, D J;
- Chimento, D;
- Riedel, E;
- Chen, X;
- Reich, L;
- Comenzo, R;
- Giralt, S;
- Hassoun, H
Publication type:
Article
Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients' monitoring after transplantation.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 3, p. 419, doi. 10.1038/bmt.2012.151
By:
- Zamarin, D;
- Giralt, S;
- Landau, H;
- Lendvai, N;
- Lesokhin, A;
- Chung, D;
- Koehne, G;
- Chimento, D;
- Devlin, S M;
- Riedel, E;
- Bhutani, M;
- Babu, D;
- Hassoun, H
Publication type:
Article
High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease.
Published in:
Bone Marrow Transplantation, 2008, v. 42, n. 6, p. 405, doi. 10.1038/bmt.2008.179
By:
- Hassoun, H.;
- Flombaum, C.;
- D'Agati, V. D.;
- Rafferty, B. T.;
- Cohen, A.;
- Klimek, V. M.;
- Boruchov, A.;
- Kewalramani, T.;
- Reich, L.;
- Nimer, S. D.;
- Comenzo, R. L.
Publication type:
Article
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial.
Published in:
Bone Marrow Transplantation, 2005, v. 35, n. 5, p. 441, doi. 10.1038/sj.bmt.1704779
By:
- Gupta, S.;
- Zhou, P.;
- Hassoun, H.;
- Kewalramani, T.;
- Reich, L.;
- Costello, S.;
- Drake, L.;
- Klimek, V.;
- Dhodapkar, M.;
- Teruya-Feldstein, J.;
- Hedvat, C.;
- Kalakonda, N.;
- Fleisher, M.;
- Filippa, D.;
- Qin, J.;
- Nimer, S. D.;
- Comenzo, R. L.
Publication type:
Article
Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance.
Published in:
Leukemia (08876924), 2013, v. 27, n. 12, p. 2422, doi. 10.1038/leu.2013.126
By:
- Zamarin, D;
- Devlin, S M;
- Arcila, M E;
- Landau, H;
- Lesokhin, A;
- Lendvai, N;
- Chung, D J;
- Chimento, D;
- Weltz, J;
- Babu, D;
- Giralt, S;
- Hassoun, H
Publication type:
Article
Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis.
Published in:
Leukemia (08876924), 2013, v. 27, n. 4, p. 823, doi. 10.1038/leu.2012.274
By:
- Landau, H;
- Hassoun, H;
- Rosenzweig, M A;
- Maurer, M;
- Liu, J;
- Flombaum, C;
- Bello, C;
- Hoover, E;
- Riedel, E;
- Giralt, S;
- Comenzo, R L
Publication type:
Article
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma.
Published in:
Leukemia (08876924), 2013, v. 27, n. 1, p. 220, doi. 10.1038/leu.2012.236
By:
- Witzig, T E;
- Laumann, K M;
- Lacy, M Q;
- Hayman, S R;
- Dispenzieri, A;
- Kumar, S;
- Reeder, C B;
- Roy, V;
- Lust, J A;
- Gertz, M A;
- Greipp, P R;
- Hassoun, H;
- Mandrekar, S J;
- Rajkumar, S V
Publication type:
Article
Results of a phase I/II trial adding carmustine (300 mg/m<sup>2</sup>) to melphalan (200 mg/m<sup>2</sup>) in multiple myeloma patients undergoing autologous stem cell transplantation.
Published in:
Leukemia (08876924), 2006, v. 20, n. 2, p. 345, doi. 10.1038/sj.leu.2404003
By:
- Comenzo, R. L.;
- Hassoun, H.;
- Kewalramani, T.;
- Klimek, V.;
- Dhodapkar, M.;
- Reich, L.;
- Teruya-Feldstein, J.;
- Fleisher, M.;
- Filippa, D.;
- Nimer, S. D.
Publication type:
Article
Epidemics and local governments in struggling nations: COVID-19 in Lebanon.
Published in:
PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262048
By:
- Al-Mulki, Jida M.;
- Hassoun, Mahmoud H.;
- Adib, Salim M.
Publication type:
Article
Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone.
Published in:
British Journal of Haematology, 2008, v. 143, n. 3, p. 369, doi. 10.1111/j.1365-2141.2008.07327.x
By:
- Lebovic, D.;
- Hoffman, J.;
- Levine, B. M.;
- Hassoun, H.;
- Landau, H.;
- Goldsmith, Y.;
- Maurer, M. S.;
- Steingart, R. M.;
- Cohen, A. D.;
- Comenzo, R. L.
Publication type:
Article

Found: 15